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Abstract
Introduction: Magnetic resonance imaging (MRI) using field strengths up to 3 Tesla (T) has proven to be a powerful tool for
stroke diagnosis. Recently, ultrahigh-field (UHF) MRI at 7 T has shown relevant diagnostic benefits in imaging of neurological
diseases, but its value for stroke imaging has not been investigated yet. We present the first evaluation of a clinically feasible
stroke imaging protocol at 7 T. For comparison an established stroke imaging protocol was applied at 3 T.
Methods: In a prospective imaging study seven patients with subacute and chronic stroke were included. Imaging at 3 T
was immediately followed by 7 T imaging. Both protocols included T1-weighted 3D Magnetization-Prepared Rapid-
Acquired Gradient-Echo (3D-MPRAGE), T2-weighted 2D Fluid Attenuated Inversion Recovery (2D-FLAIR), T2-weighted 2D
Fluid Attenuated Inversion Recovery (2D-T2-TSE), T2* weighted 2D Fast Low Angle Shot Gradient Echo (2D-HemoFLASH)
and 3D Time-of-Flight angiography (3D-TOF).
Results: The diagnostic information relevant for clinical stroke imaging obtained at 3 T was equally available at 7 T. Higher
spatial resolution at 7 T revealed more anatomical details precisely depicting ischemic lesions and periinfarct alterations. A
clear benefit in anatomical resolution was also demonstrated for vessel imaging at 7 T. RF power deposition constraints
induced scan time prolongation and reduced brain coverage for 2D-FLAIR, 2D-T2-TSE and 3D-TOF at 7 T versus 3 T.
Conclusions: The potential of 7 T MRI for human stroke imaging is shown. Our pilot study encourages a further evaluation
of the diagnostic benefit of stroke imaging at 7 T in a larger study.
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Introduction
Magnetic resonance imaging (MRI) using field strengths up to 3
Tesla (T) has proven to be a powerful imaging modality for the
diagnosis of stroke and for the assessment of infarct morphology
and stroke etiology [1]. For a few years, ultrahigh-field (UHF)
MRI at 7 T has been available for imaging in humans. Recent
reports demonstrated the use of UHF MRI at 7 T for brain
imaging and showed relevant diagnostic benefits for brain tumors
[2], cerebral malformations [3], Parkinsons’s disease [4] and
multiple sclerosis [5]. The sensitivity gain inherent to UHF MRI at
7 T allows for enhanced spatial resolution versus 3 T MRI and
holds the promise of new diagnostic approaches for brain
pathologies [6]. However, 7 T MRI is not yet available for
routine clinical imaging and the potential of UHF MR for stroke
imaging in clinical practice has yet to be fully realized. Preliminary
experience with MRI at 7 T in stroke patients is limited to reports
of time-of-flight angiography (TOF) [7] and vessel wall imaging
[8]. On one hand, the sensitivity advantage inherent to MRI at 7
T offers the potential to gain new insights into stroke pathology.
On the other hand, diagnostic information derived from MRI at 7
T has to be carefully validated against stroke MRI at 1.5 T or 3 T.
Realizing this opportunity, our study examines the feasibility of
stroke imaging at 7 T. For this reason, we propose and evaluate a
clinically feasible stroke protocol for subacute and chronic stroke
at 7 T. For comparison, a clinically established standard imaging
protocol was used at 3 T.
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Ethics Statement
All patients gave informed written consent prior to the study.
The study was conducted according to the principles expressed in
the Declaration of Helsinki and was approved by the authorized
ethical review board (ERB), the governmental Berlin state ERB,
and the relevant German state authority, The Federal Institute for
Drugs and Medical Devices.
Study Design
We initiated an observational prospective imaging study (7
Tesla Ultra-High Field Project, 7UP, WHO International
Clinical Trials Registry No. DRKS00003193, http://apps.who.
int/trialsearch/Trial.aspx?TrialID=DRKS00003193). Between
August 2011 and December 2011, 298 consecutive patients
either admitted with stroke to the Departments of Neurology of
the Charite ´-Universita ¨tsmedizin Berlin or presenting at stroke
out-patient services were screened. Inclusion criteria were: 1)
subacute/chronic stroke or transient ischemic attack (TIA), 2) age
18–80 years, 3) ability to give informed consent and 4) legal
competence. Exclusion criteria were: 1) cardiac pacemakers or
any other electronic implants, 2) metallic implants, 3) pregnancy
or breast feeding period, 4) claustrophobia, 5) chronic or episodic
vertigo, 6) retinal diseases and 7) dental bridges and more than
two metallic dental crowns in a row. Neurological status was
assessed by the National Institute of Health Stroke Scale (NIHSS)
at the time of admission for index stroke and before MR
imaging. Imaging was performed first at 3 T, immediately
followed by imaging at 7 T. A stroke neurologist supervised the
patients during imaging.
Magnetic Resonance Imaging Hardware
MR-imaging was performed on a 3 T whole-body system
(Magnetom Verio, Siemens Healthcare, Erlangen, Germany)
using a 12 channel receive RF coil (Siemens Healthcare, Erlangen,
Germany) tailored for head imaging. At 7 T, a whole body system
(Magnetom 7T, Siemens Healthcare, Erlangen, Germany)
equipped with a 90 cm bore magnet (Magnex Scientific,
Oxfordshire, UK) and an Avanto gradient system (Siemens
Healthcare, Erlangen, Germany) was used together with a 1/24-
channel transmit/receive coil (Model NM 008-23-7S, NovaMedi-
cal, Wakefield, MA, USA) designed for head imaging.
Magnetic Resonance Imaging Parameters
At both 3 T and 7 T the imaging protocol included the
following imaging techniques:
N T1-weighted 3D Magnetization-Prepared Rapid-Acquired
Gradient-Echo (3D-MPRAGE)
N T2-weighted 2D Fluid Attenuated Inversion Recovery (2D-
FLAIR)
N T2-weighted 2D Turbo Spin Echo (2D-T2-TSE)
N T2* weighted 2D Fast Low Angle Shot Gradient Echo (2D-
HemoFLASH)
N 3D Time-of-Flight angiography (3D-TOF).
All sequences were modified based on standard imaging
protocols provided by the MR-manufacturer. T2-TSE and
HemoFLASH were adapted according to [9]. Imaging parameters
used at 3 T and 7 T are shown in Table 1.
Data Postprocessing and Image Analysis
Co-registration of images was performed with VINCI, Version
3.90 (Max-Planck-Institute for Neurological Research, Cologne,
Germany) [10]. Visual analysis of the acquired images was
performed with OsiriX, Version 4.0 (Pixmeo, Geneva, Switzer-
land) using a standardized qualitative evaluation including the
following items (applicable sequences are listed in brackets): 1)
number of lesions (FLAIR, MPRAGE, T2-TSE), 2) lesion
morphology (FLAIR, MPRAGE, T2-TSE), 3) contrast between
lesions and healthy tissue (FLAIR, MPRAGE, T2-TSE) and 4)
assessment of the anatomical detail level (FLAIR, MPRAGE, T2-
TSE, HemoFLASH). Unique information provided by specific
sequences was assessed: 5) perilesional hemosiderin deposits
(HemoFLASH) and 6) vessel morphology (TOF). Evaluation of
these items was performed on a consensus basis by J.S. and J. W.
Results
Seven patients (3 females, median age 42 years, interquartile
range [IQR] 35–55) received imaging at 3 T and 7 T. Two
patients were imaged in the subacute phase (13 and 14 days after
stroke), 5 patients were imaged in the chronic phase (median years
after stroke 1.6, IQR 1.3–5.2). All examinations were well
tolerated by the patients, no adverse events occurred. Detailed
patient data are shown in table 2.
The mean value of the total examination time including 3D-
MPRAGE, 2D-FLAIR, 2D-T2-TSE, 2D-HemoFLASH, 3D-TOF
was 24:06 min at 7 T and 17:26 min at 3 T.
2D-FLAIR-imaging
In all patients, the number of visible ischemic lesions was
identical at both field strengths (see table 2). The depiction of the
lesion morphology was superior at 7 T versus 3 T. The contrast
between stroke lesions and healthy brain tissue was inferior at 7 T.
In comparison, the depiction of white matter lesions (WML) at 7 T
was superior owing to better contrast between WMLs and healthy
tissue as demonstrated in figure 1.
3D-MPRAGE-imaging
The number of visible ischemic lesions was identical at both
field strengths. For all patients, MPRAGE at 7 T depicted the
internal structure of stroke lesions with higher detail compared
with 3 T. Contrast between lesions and healthy tissue was superior
at 7 T. Small brain structures like Virchow-Robin spaces (VRS)
were visualized in much higher anatomical detail and were more
frequent at 7 T. Exemplary images are presented in figure 2.
2D-T2-TSE imaging
The number of visible ischemic lesions was identical at both
field strengths. T2-weighted imaging at 7 T was superior to 3 T in
terms of lesion morphology, visible contrast between ischemic
lesions and healthy tissue/cerebrospinal fluid (CSF) and the
depiction of anatomical details such as VRS. However, in 7 T T2-
TSE imaging we observed artifacts in 5 out of 7 patients, which
occurred exclusively for 2D T2-weighted imaging (see discussion).
Exemplary images are presented in figure 3.
2-D-HemoFLASH imaging
In all patients, HemoFLASH at 7 T provided higher anatomical
detail and allowed for a clearly better detection and delineation of
perilesional hemosiderin deposits compared with HemoFLASH
imaging at 3 T. In one patient (fig. 4, C), an incidental cavernous
angioma was found at both field strengths. At 7 T, its internal
structure and the feeding vessels were presented in much more
Ultrahighfield MRI of Stroke at 7 T
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HemoFLASH imaging are depicted in figure 4.
3D-TOF imaging
TOF imaging at 7 T displayed more first and second order
branches of the major brain arteries in all patients owing to
improved lumen/background contrast in conjunction with
enhanced spatial resolution. Stenoses of the intracranial arteries
were not found at both field strengths. Angiographies derived from
TOF acquisitions at 3 T and 7 T are shown in figure 5.
Discussion
We report on the first head-to-head comparison of a clinically
feasible stroke imaging protocol at 3 T and 7 T in subacute and
chronic stroke patients. Our data suggest that the diagnostic
information present at 3 T is also available at 7 T. Moreover, we
found that the higher spatial resolution at 7 T reveals more
anatomical details of ischemic lesions and normal brain anatomy.
Owing to improved spatial resolution and enhanced contrast
mechanisms such as microscopic susceptibility-effects and T1
prolongation,MRIat7Tpromisestobebeneficialforthediagnosis
of neurological diseases. And indeed, previous reports on other
neurological diseases using UHF-MRI were encouraging, e.g. in
brain tumors [2], cerebral malformations [3] Parkinsons’s disease
[4]andmultiplesclerosis[5].Mostofpreviousbrainimagingstudies
at 7 T focused on basic research and did not regard relevant clinical
issuesasforexampletheexaminationtimeorbraincoverage[8].To
establish a 7 T stroke protocol for clinical use, specific needs have to
be met: First, clinical stroke imaging at 7 T has to provide the same
diagnosticinformation,e.g.visibilityofischemiclesions,asprotocols
commonly used in current clinical practice at lower field strengths.
Second, the total acquisition time achievable at 7 T should be
comparable to established protocols at lower field strengths. Third,
the imaging techniques at 7 T should be based on broadly available
standard imaging protocols. From a technical point of view, RF coil
design,limitedavailabilityofRFcoilstailoredforbrainimaging,B0-
and B1-field inhomogeneities, increased T1 relaxation, decreased
T2 relaxation and increased RF power deposition in the patient
present practical challenges at 7 T. In establishing a stroke imaging
protocol for 7 T, we therefore focused on the modification of
available standardprotocolsestablishedatlowerfieldstrengthswith
the goal to balance the competing constraints of spatial resolution,
RF power deposition, image quality and acquisition time.
2D-FLAIR imaging
Using FLAIR, all subacute and chronic lesions shown at 3 T
were also readily visible at 7 T (see table 2). Given that T2-FLAIR
imaging is the clinical standard for the imaging of subacute and
chronic stroke lesions, our results strongly suggest that a similar
contrast and therefore important diagnostic information available
at 3 T is also available at 7 T. Also, we found WMLs to be better
delineated from healthy tissue. However, the inversion pulse and
multiple refocusing pulses intrinsic to FLAIR sequences resulted in
higher RF power deposition at 7 T in comparison with 3 T. In
order not to exceed RF power deposition limits, the number of
slices needed to be reduced from 20 to 11 (inferior-superior brain
coverage: 3.6 cm), resulting in an acquisition time that was only 54
s longer than at 3T. Without doubt, however, whole brain
coverage as used at 3 T is essential for a clinical imaging protocol
at 7 T. Recently introduced 3D FLAIR-techniques have the
potential to overcome the limitations of the protocol used in our
study [9,11]. 3D-FLAIR will also support statistical comparison of
the number of WMLs depicted at different field strengths.
Recently, it has also been suggested that 7 T FLAIR might allow
for the improved detection of microinfarcts [12].
On the one hand, 7 T MRI promises unique diagnostic benefits.
On the other hand, it can be used for clinical imaging only, if the
diagnostic information available at 3 T (or 1.5 T) can be obtained
at 7 T as well. Therefore, our finding that FLAIR imaging at 7 T is
equivalent to 3 T with respect to infarct detection is important and
encouraging for further studies.
3D-MPRAGE imaging
Using MPRAGE, 7 T showed a clear improvement in the
visualization of anatomical structures and lesion details at 7 T (e.g.
morphology, shape and borders of the ischemic lesions and
morphology and number of Virchow-Robin spaces,). To achieve a
contrast comparable to 3 T, a longer TR was chosen at 7 T due to
T1 prolongation. Using parallel imaging (acceleration factor=2)
our MPRAGE acquisition time was only slightly increased
compared with 3 T without sacrificing the spatial resolution
advantage over the 3 T approach. Moreover, our protocol
facilitated RF power deposition levels, which did not exceed the
Table 2. Clinical data of imaged patients.
No
Age
(years) Sex Site of Stroke
NIHSS
(admission/imaging)
Stroke to Imaging
(days [d] or years [y])
No. of stroke
lesions at 3 T / 7 T
1 41 m MCA L+R 4/0 14 d 4/4
2 56 m TIA 1/0 13 d 0/0
3 51 m MCA L 1/0 0.4 y 3/3
4 28 m MCA L 7/2 7.2 y 1/1
5 42 f MCA L 3/2 4.5 y 1/1
6 70 f MCA L 5/0 1.3 y 1/1
7 28 f PCA L+R 0/0 1.6 y 2/2
Median 42 3/0 1.6 y
IQR 35–55 1–5/0–2 1.3–5.2 y
m: male; f: female; MCA: medial cerebral artery; TIA: transitory ischemic attack; PCA: posterior cerebral artery, R: right; L: left; NIHSS: National Institutes of Health Stroke Scale;
Stroke to Imaging: time delay between admission and MRI scans; IQR: interquartile range; in the last column only chronic patients (bold) served as basis of calculation of
median and IQR.
doi:10.1371/journal.pone.0037631.t002
Ultrahighfield MRI of Stroke at 7 T
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coverage MPRAGE at 7 T was feasible for our protocol.
MPRAGE at 7 T as used in our protocol therefore offers an
unprecedented depiction of anatomical details of stroke lesions. As
a result, the correlation of stroke location and neurological
symptoms especially in brain regions with a high density of nuclei
with different functions, e.g. the thalamus, will be greatly
facilitated. Furthermore, the number and enlargement of VRS
may be correlated with aging, dementia and signs of small vessel
disease, a risk factor of stroke [13–15]. MPRAGE at 7 T seems to
be better suited to assess number and size of VRS in stroke
patients than imaging at lower field strengths, thus potentially
facilitating research in this area.
T2-weighted imaging
For T2-weighted imaging, stroke lesions and small brain
structures like VRS could be depicted in higher detail at 7 T in
comparison with 3 T. In contrast to the other techniques used we
observedimageartifactsfor T2-weightedimagingat7T,whichcan
be attributed to bulk head motion. Given that other sequences were
not affected, adaptation of motion artifact reducing techniques
[16,17]willhelptofurtherimprovethevalueofT2-TSE-imagingat
Figure 1. Comparison of T2-FLAIR images obtained at 3 T and 7 T. In all patients, all lesions detected at 3 T were also visible at 7 T. Boxed
areas are shown at higher magnification. A) Patient No. 3, with a small chronic lesion consisting of hyperintense postischemic tissue (white
arrowheads) surrounding a tissue defect area (asterisk); compare also figure 2 A. At 7 T, the intensity values of the tissue defect area were comparable
to CSF, while at 3 T, the intensity values were comparable to white matter. Contrast between postischemic and healthy brain tissue was higher at 3 T.
However, small white matter lesions (red arrowheads) were easier to identify at 7 T. B) Patient No. 1, with a chronic stroke lesion (white arrowheads)
and a subacute lesion (red arrowheads). Both lesion types were readily identifiable at both field strengths. As in A), contrast between the lesion and
healthy tissue appeared to be higher at 3 T. C) Patient No. 4, with a large chronic infarct, consisting of hyperintense lesion areas (white arrowheads)
and hypointense defect areas (asterisks). Again, CSF-filled tissue defect areas were easier to identify at 7 T, while the lesion to healthy tissue contrast
was higher at 3 T. Compare also fig. 2 A–C.
doi:10.1371/journal.pone.0037631.g001
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owing to the use of a train of refocusing RF pulses. We were able to
acquire20slicesperpatient(superior-inferior[S-I]coverage:7 cm),
which can be considered sufficient, if the site of the lesion is known.
However, more slices or even whole brain coverage would be
desirableinthefutureandacquisitiontimeat7Twasalmost3 times
longerthanat3T(3:36 minvs1:20).Here,theuseofRFrefocusing
pulses lower than 180 degrees or the application of specific
absorption rate saving techniques, which modulate the amplitude
oftherefocusingRFpulses[18,19],canbehelpfultooffsetRFpower
deposition constraints.
2D-HemoFLASH
HemoFLASH is a 2D FLASH sequence with relatively long TE
sensitiveforbloodandbloodproductslikehemosiderin(9).Instroke
lesions, the detection of hemosiderin deposits and microbleeds is of
majorimportance[20,21].HemoFLASHat7Twasclearlysuperior
to HemoFLASH at 3 T in terms of spatial resolution, anatomical
detailandindepictingperilesionalhemosiderindeposits.Moreover,
Figure 2. Comparison of T1-weighted images derived from T1-MPRAGE at 3 T and 7 T. In all patients, MPRAGE at 7 T depicted the internal
structure of stroke lesion in higher detail compared with 3 T. Boxed areas are shown at higher magnification. A) Patient No. 3. The tissue defect area
appeared larger and less well confined at 3 T in contrast to 7 T (white arrowheads). Virchow-Robin spaces were seen in more detail and higher
frequency at 7 T (red arrowheads). B) In patient No. 1, the chronic stroke lesion (white arrowheads) presented as an hypointense area – indicating
gliosis – and as a disruption of the cortical band. These characteristics of the lesion were depicted in higher detail level and contrast at 7 T. The
subacute lesion (red arrowheads) showed a different internal structure of the cortical band compared with healthy cortex. Within the lesion, the
cortical band was divided into a superficial hyperintense layer and a deeper hypointense layer (asterisks). Differentiation of the two layers was much
easier at 7 T. C) Patient No. 4. In this large infarct, differentiation of hypointense gliosis (white arrowheads) and healthy tissue was again clearer at 7 T.
Inhomogeneities between the frontal and occipital cortex and paramedian deep structures – typical for 7 T – were more pronounced in this patient
compared to A) and B).
doi:10.1371/journal.pone.0037631.g002
Ultrahighfield MRI of Stroke at 7 T
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7 T was comparable to 3 T, while whole brain coverage was
achieved with more slices than at 3 T (45 vs. 25). Considering the
superior depiction of an incidentally found cavernous angioma at 7
T, our results suggest potential diagnostic benefits using Hemo-
FLASH imaging at 7 T in the future.
3D-TOF
TOFat7Twasabletoshowmorefirstandsecondorderbranches
of the major vessels in our study. These results in stroke patients are
in accordance with previous reports on TOF-imaging at 7 T [7,22].
TOF is challenging at 7 T owing to high RF power deposition that
leads to long acquisition times and to an incomplete brain coverage
(S-I coverage is approximately 5 cm at 7 T vs. 8 cm at 3 T, when
using the imaging paramters shown in table 2). This renders 7 T
currently suitable for a detailed visualization of selected brain
regions but not for a screening method of the whole basal
intracranial vessel system. Moreover, since no patient in our sample
showed vessels stenoses, the potential of TOFat 7T for the imaging
ofintracranialmacroangiopathyremainstobeevaluated.Giventhe
superiorityintermsofspatialresolution,however,acleardiagnostic
benefitintheimagingofdiseaseswithaffectionofmacro-vessels,eg.
atherosclerosis or cerebral vasculitis, can be expected in the future.
In summary, 7 T offered substantial benefits over 3 T imaging
in stroke with respect to improved spatial resolution and depiction
of the infarct and vessel morphology as well as stroke related
Figure 3. Comparison of T2-weighted imaging performed at 3 T and 7 T. Boxed areas are shown at higher magnification. A) In patient No. 3,
artifacts were present (red arrowheads). Contrast and detail level of the lesion (white arrowhead) and of Virchow-Robin spaces were not higher at 7 T.
B) In contrast, in patient No. 1 no artifacts were present. Virchow Robin spaces (white arrowheads) were depicted in higher detail at 7 T and the
delineation of the lesion (red arrowheads) from healthy tissue was higher at 7 T. C) Same patient as in B). Also in the region of the deep nuclei T2-
weighted imaging at 7 T showed better delineation, e.g. between deep nuclei (red asterisks) and fibre bundles of the internal capsule (white
asterisks).
doi:10.1371/journal.pone.0037631.g003
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substantiate a preliminary report on stroke imaging at 8 T, where
diagnostic advantages over imaging at 1.5 T were described [23].
The introduction of promising new technologies such as 7 T
requires the proof of a diagnostic benefit over routinely used
methods to justify the translation into clinical use. Our initial
results show benefits in several aspects of 7 T MRI for the imaging
of ischemic lesions and intracranial vessels. Thus, our data favor a
further exploration of UHF MRI at 7 T to investigate the specific
benefit for stroke imaging. However, we also identified techno-
logical and practical challenges such as limited brain coverage
owing to SAR constraints, longer acquisition times and suscepti-
bility to motion (T2-imaging), which need to be solved before
clinical use. These technical improvements are part of our ongoing
study.
Our preliminary study has several limitations. First, we present a
limited number of patients that precludes a concluding judgment of
the valueof7TMRI.Giventhatalmost300patients werescreened
for our study, the number of patients imaged reflects the cautious
exclusion criteria, which have to be applied to UHF MRI at 7 T
according to our ERB approval. However, our study reports on a
unique comparison of 3 T and 7 T imaging in stroke and serves as a
Figure 4. Comparison of T2*-weighted images acquired with HemoFLASH at 3 T and 7 T. In all patients, HemoFLASH provided higher
anatomic detail level at 7 T. Moreover, hypointense perilesional hemosiderin deposits were much more pronounced at 7 T. Boxed areas are shown at
higher magnification. A) In patient No 3, anatomical detail level and contrast of the lesion (white arrowheads) to healthy tissue were higher at 7 T
imaging. T2-FLAIR weighted high magnification images are shown for comparison below. A perilesional hypointense area, indicating hemosiderin
deposits, was much more pronounced at 7 T (red arrowheads). B) In patient No. 4, again both anatomical details as well as the imaging of
hemosiderin (white arrowheads) were superior at 7 T. C) Incidental finding of a cavernous angioma (white arrowhead) in patient No. 5. The internal
structure of the lesion, showing a nodular characteristic with a hypointense rim, and the depiction of feeding vessels were more pronounced at 7 T,
facilitating the diagnosis.
doi:10.1371/journal.pone.0037631.g004
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challenges and benefits of stroke imaging at ultrahigh magnetic
fields.
Second, owing to the strict exclusion criteria the median age of
the patients imaged in our study (42 a) was lower and thus not
representative for the general stroke population. Along with the
increasing use of 7 T MRI and the advancing clinical experience,
the use of stroke imaging at 7 T in a broader patient population is
to be expected.
Third, our comparison is a visual and therefore qualitative
analysis. Our study is ongoing and with increasing patient
numbers, a quantitative approach will be targeted.
Fourth, the diagnostic value of MRI mainly depends on the
imaging parameters as well as the scanning time. The 7 T protocol
– while clinically acceptable – yielded an acquisition time which
exceeded that of the 3 T protocol (24 min vs 17 min). Further
emphasis on shortening the acquisition times, while maintaining
superior spatial resolution without losing diagnostic information, is
still necessary and part of our ongoing investigations.
Fifth, only subacute and chronic stroke patients were included
in this study. In the future, the value of 7 T MRI should be
evaluated in acute stroke patients. Our study paves the way for the
clinical use of 7 T MRI in stroke. However, diffusion weighted
imaging (DWI), the clinical standard of acute stroke MR imaging,
does not offer sufficient image quality at 7 T yet (8) and will need
further development.
Sixth, most of the patients imaged had mild strokes with small
lesions. With broader availability of 7 T imaging, better
accessibility of 7 T MRI for patients with more severe disabilities
can be expected.
In conclusion, stroke lesions visible at 3 T can all be detected at
7 T. 7 T imaging of stroke provides improved spatial resolution
which helps to reveal more anatomical detail and pathophysio-
logical characteristics of ischemic lesions. Our findings encourage
a further exploration of the diagnostic benefit 7 T MRI may offer
for the imaging of stroke. RF power, acquisition time and limited
brain coverage constraints present challenges in some of the
sequences for stroke imaging at 7 T, but should inspire basic
researchers and clinical scientists to throw further weight behind
the solution of the remaining technical problems.
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Figure 5. Comparison of MR-angiographies derived from 3D TOF acquisitions at 3 T and 7 T. In all patients, TOF at 7 T was able to depict
the branches of the main cerebral arteries in higher anatomical detail. In patients No. 4 (A) and No. 7 (B), the left MCA territory is shown in higher
magnification. In comparison with 3 T, clearly more first and second order branches were visible at 7 T in comparison with 3 T (white arrowheads).
doi:10.1371/journal.pone.0037631.g005
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